Skip to content
Advertisement

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

In this Dec. 13, 2020, photo, boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich. The U.S. death toll from the coronavirus topped 300,000 Monday, Dec. 14, just as the country began dispensing COVID-19 shots in a monumental campaign to conquer the outbreak. (AP Photo/Morry Gash, Pool) **FILE**

COVID-19 death toll hits 300K in U.S.

The U.S. coronavirus death toll surpassed a once-unfathomable 300,000 on Monday, creating a sorrowful split screen with the immunization campaign that kicked off across the country. Published December 14, 2020

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020. (AP Photo/Morry Gash, Pool)

Coronavirus vaccine shipments to arrive Monday in every state

Boxes of coronavirus vaccines rolled off assembly lines in Michigan on Sunday, launching a historic campaign to immunize Americans against the pathogen that's upended normal life and killed nearly 300,000 people in the U.S. since its discovery in China one year ago. Published December 13, 2020

A truck loaded with the Pfizer-BioNTech COVID-19 vaccine leaves the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020. (AP Photo/Morry Gash, Pool)

First Pfizer vaccines leave warehouse

Boxes of drugmaker Pfizer's coronavirus vaccines rolled off assembly lines in Michigan while the cameras rolled early Sunday. Published December 13, 2020

The Pfizer Global Supply Kalamazoo manufacturing plant is shown in Portage, Mich., Friday, Dec. 11, 2020. The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans. (AP Photo/Paul Sancya)

First Pfizer vaccines to arrive in states Monday

Initial shipments of Pfizer's coronavirus vaccine will arrive at nearly 150 sites across all the states on Monday, President Trump's vaccine team said Saturday. Published December 12, 2020

A vial of the Pfizer-BioNTech COVID-19 vaccine at the Royal Victoria Hospital, in Belfast, Tuesday, Dec. 8, 2020. The United Kingdom, one of the countries hardest hit by the coronavirus, is beginning its vaccination campaign, a key step toward eventually ending the pandemic. (Liam McBurney/Pool via AP)

FDA approves Pfizer coronavirus vaccine for emergency use

The Food and Drug Administration approved Pfizer's coronavirus vaccine for emergency use late Friday, launching an historic campaign to inoculate millions of Americans against a disease that's upended normal life, pummeled the economy and killed nearly 300,000 in the U.S. Published December 11, 2020

A vial of the Pfizer-BioNTech COVID-19 vaccine at the Royal Victoria Hospital, in Belfast, Tuesday, Dec. 8, 2020. The United Kingdom, one of the countries hardest hit by the coronavirus, is beginning its vaccination campaign, a key step toward eventually ending the pandemic. (Liam McBurney/Pool via AP)

Pfizer coronavirus vaccine approved by panel clearing FDA EUA path

An influential panel on Thursday recommended approving Pfizer's coronavirus vaccine, clearing a path for the Food and Drug Administration to grant emergency approval so that states can inoculate health care workers and nursing home residents. Published December 10, 2020

In this file photo dated Wednesday, July 22, 2020, a Pfizer sign is seen on a podium at the Pfizer Research & Development Laboratories, in Groton, Conn. (AP Photo/Stew Milne)  **FILE**

Key FDA panel debates Pfizer vaccine

A government advisory panel is debating Pfizer's coronavirus vaccine Thursday and will decide whether its benefits outweigh any risks, clearing a path for the Food and Drug Administration to grant emergency approval so that states can begin to inoculate health workers and nursing-home residents. Published December 10, 2020

A nurse holds a vial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020, as the U.K. health authorities rolled out a national mass vaccination program. (AP Photo/Frank Augstein, Pool)

Operation Warp Speed: We won’t fiddle with Pfizer dosing plan

Leaders of Operation Warp Speed said Wednesday they will not abandon plans to reserve half of the available Pfizer doses when the coronavirus vaccine campaign launches in the coming days, even though new data showed a level of protection after the first shot of the two-dose regimen. Published December 9, 2020

In this Oct. 10, 2020, photo, President Donald Trump speaks from the Blue Room Balcony of the White House to a crowd of supporters in Washington. (AP Photo/Alex Brandon) ** FILE **

Trump taunts doubters, citing speed of vaccine

President Trump declared victory over naysayers Tuesday, saying he sped multiple COVID-19 vaccines through the pipeline in a single year, while nudging the Food and Drug Administration to approve Pfizer's version this week. Published December 8, 2020

Members of President Donald Trump's legal team, including former Mayor of New York Rudy Giuliani, left, Sidney Powell, and Jenna Ellis, speaking, attend a news conference at the Republican National Committee headquarters, Thursday Nov. 19, 2020, in Washington. (AP Photo/Jacquelyn Martin) **FILE**

Jenna Ellis, pro-Trump attorney, tells others she has coronavirus: Report

Jenna Ellis, an attorney boosting President Trump's bid to contest the election results, has told people she tested positive for the coronavirus, according to a report in Axios that says the Rudolph W. Giuliani sidekick attended a White House Christmas party Friday. Published December 8, 2020

In this file photo, Paula McMahon prepares a shot of the Pfizer-BioNTech COVID-19 vaccine, as the mass public vaccination program gets underway, at the NHS Louisa Jordan Hospital in Glasgow, Scotland, Tuesday Dec. 8, 2020. On Dec. 8, 2020, the FDA released a 53-page briefing document with findings showing the vaccine is effective after the first dose. (Jeff J Mitchell/Pool via AP)

Pfizer vaccine offers protection after the first dose: FDA

The Food and Drug Administration said data from Pfizer shows its vaccine reduced the risk of COVID-19 after the first dose and was "consistent" with regulators' recommendations for emergency approval, signaling a promising start to a review that will unfold this week and likely kickstart the U.S. immunization campaign. Published December 8, 2020

In this Monday, July 27, 2020, file photo, a nurse prepares a syringe during a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. (AP Photo/Hans Pennink)

White House denies report it rejected Pfizer coronavirus vaccine doses

The White House said Monday a report suggesting it passed up coronavirus vaccine doses from Pfizer is "false" and it believes there will be sufficient doses from multiple drugmakers to immunize all Americans who desire the shots by the second quarter of 2021. Published December 7, 2020